Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Zalasta“
Suchtreffer
Begriffe & Kennungen
Zalasta · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP 1A2 inhibitor, has been shown to significantly inhibit the me
Eintrag öffnenZalasta · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP 1A2 inhibitor, has been shown to significantly inhibit the me
Eintrag öffnenZalasta · 4.5 · Interaction studies have only been performed in adults.
Eintrag öffnenZalasta · 4.5 · Interaction studies have only been performed in adults.
Eintrag öffnenZalasta · 4.5 · Olanzapine does not inhibit the main CYP450 isoenzymes in vitro (e.g. 1A2, 2D6, 2C9, 2C19, 3A4). Thus no parti
Eintrag öffnenZalasta · 4.5 · Olanzapine does not inhibit the main CYP450 isoenzymes in vitro (e.g. 1A2, 2D6, 2C9, 2C19, 3A4). Thus no parti
Eintrag öffnenZalasta · 4.5 · Olanzapine showed no interaction when co-administered with lithium or biperiden.
Eintrag öffnenZalasta · 4.5 · Potential for olanzapine to affect other medicinal products Olanzapine may antagonise the effects of direct an
Eintrag öffnenZalasta · 4.5 · Potential for olanzapine to affect other medicinal products Olanzapine may antagonise the effects of direct an
Eintrag öffnenZalasta · 4.5 · Potential interactions affecting olanzapine Since olanzapine is metabolised by CYP1A2, substances that can spe
Eintrag öffnenZalasta · 4.5 · Potential interactions affecting olanzapine Since olanzapine is metabolised by CYP1A2, substances that can spe
Eintrag öffnenZalasta · 4.5 · QTc interval Caution should be used if olanzapine is being administered concomitantly with medicinal products
Eintrag öffnenZalasta · 4.5 · QTc interval Caution should be used if olanzapine is being administered concomitantly with medicinal products
Eintrag öffnenZalasta · 4.5 · The concomitant use of olanzapine with anti-Parkinsonian medicinal products in patients with Parkinson's disea
Eintrag öffnenZalasta · 4.5 · The concomitant use of olanzapine with anti-Parkinsonian medicinal products in patients with Parkinson's disea
Eintrag öffnenZalasta · 4.5 · Therapeutic monitoring of valproate plasma levels did not indicate that valproate dosage adjustment is require
Eintrag öffnenZalasta · 4.5 · Therapeutic monitoring of valproate plasma levels did not indicate that valproate dosage adjustment is require
Eintrag öffnenZalasta · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenZalasta · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenZalasta · 4.8 Undesirable effects · 1
Eintrag öffnen